ASX-Dividend-Report-Banner

ZEISS continues to expand its clinical workflows and digital portfolio, presenting new tools and solutions at AAO 2023

October 27, 2023 12:00 AM AEDT | By Cision
Follow us on Google News: https://kalkinemedia.com/resources/assets/public/images/google-news.webp
 ZEISS continues to expand its clinical workflows and digital portfolio, presenting new tools and solutions at AAO 2023
Image source: Kalkine Media
  • ZEISS CT LUCIA 621P is now available for calculation on the ZEISS AI IOL Calculator.
  • New ZEISS PROSPARA digital marketing software within the ZEISS Corneal Refractive Workflow helps enhance online visibility for refractive practices.
  • ZEISS VISULAS yag therapeutic laser receives 510k clearance in the US, expanding offerings within the ZEISS Cataract Workflow.
  • New ZEISS Retina Workflow innovations further enable the management and treatment of AMD, geographic atrophy (GA), and diabetic retinopathy (DR).

JENA, Germany and DUBLIN, Calif., Oct. 26, 2023 /PRNewswire/ -- ZEISS Medical Technology will showcase digital enhancements to the cataract, corneal refractive and retina workflows at the American Academy of Ophthalmology (AAO) conference from Nov. 4-6, 2023, in San Francisco. As part of the ZEISS Medical Ecosystem, these innovations offer new digital tools to help advance clinical and patient management to a higher level of efficient and personalized care.

ZEISS AI IOL Calculator
ZEISS AI IOL Calculator

"The power of our ZEISS Medical Ecosystem becomes richer and more compelling for our customers every day. Our ecosystem and digital tools set ZEISS apart in the industry, providing our customers with new opportunities to improve treatment paths and outcomes with a more efficient and effective clinical workflow," said Euan S. Thomson, Ph.D., Head of the Ophthalmology Strategic Business Unit and Head of the Digital Business Unit for ZEISS Medical Technology. "As ZEISS continues to unlock enormous value through data-driven healthcare solutions, our aim is to provide doctors and surgeons with the most advanced, connected digital workflows to help them care for their patients in the best possible way."

ZEISS Cataract Workflow showcases surgical planning and treatment enhancements to support a better patient experience

Today, ZEISS announces the 510k clearance of the ZEISS VISULAS yag laser by the Food and Drug Administration (FDA) in the US. The ZEISS VISULAS yag provides a precise and compact laser workstation for safe and effective posterior capsulotomy and iridotomy procedures. The therapeutic laser can be connected with ZEISS FORUM1 and conveniently integrates into the ZEISS Cataract Workflow.

Additionally, the ZEISS AI IOL Calculator on ZEISS VERACITY Surgery Planner can now calculate the ZEISS CT LUCIA 621P IOL. The new ZEISS AI IOL Calculator is a data-driven IOL power calculation algorithm that uses advanced artificial intelligence (AI) and paraxial ray tracing to provide excellent IOL power calculations.2

Helping doctors boost their marketing efforts: The ZEISS Refractive Workflow showcases the ZEISS PROSPARA digital marketing software to enhance online visibility of refractive practices

In response to the growing need for a strong online presence among refractive practices, ZEISS is launching a digital marketing software solution called ZEISS PROSPARA. This cloud-based software solution provides a wide range of features to assist in enhancing online visibility, managing reputation, and social media engagement, all from a single platform. ZEISS PROSPARA is set to launch at AAO this year, with more information becoming available in November 2023.

ZEISS Retina Workflow innovations further enable the management and treatment of AMD, geographic atrophy (GA), and diabetic retinopathy (DR)

ZEISS will showcase a digitally connected retina workflow, including advanced diagnostic and surgical devices which help manage and treat retina diseases such as age-related macular degeneration (AMD), geographic atrophy (GA), and diabetic retinopathy (DR). The ZEISS CIRRUS stands alone as the only diagnostic OCT device in the market offering an AMD & GA Tool Kit - Advanced RPE Analysis3 and AngioPlex OCT Angiography - to support the early detection and management of nonexudative and exudative AMD. The ZEISS CLARUS ultra-widefield imaging fundus camera includes True Color, FAF-Green and FAF-Blue modalities, ideal for capturing and documenting AMD, GA and DR.

The ZEISS VISULAS green laser, a 532nm photocoagulator dedicated for retinal diseases, is commercially available, offering the optimal wavelength for the treatment of DR as well as an intuitive design. The ZEISS VISULAS green laser can be connected with ZEISS FORUM1 to store diagnostic reports directly from the laser workstation for a seamless integration of laser therapy as part of the ZEISS Retina Workflow.

Additionally, the ophthalmic microscope ZEISS ARTEVO 800 with integrated intraoperative OCT (RESCAN 700) helps reveal insights such as epiretinal membrane, macular edema, posterior hyaloidal traction, and retinal detachment4, allowing for strategy adjustments during surgery. Added to ZEISS ARTEVO 800 is the proven non-contact fundus viewing system RESIGHT® 700 from ZEISS, enabling surgeons to see a clear and detailed view of the retina.

ZEISS will showcase its latest offerings and new innovations at the American Academy of Ophthalmology (AAO) conference from Nov. 4-6, 2023, in booth 2321.

For more information, visit www.zeiss.com/med.

1 Connectivity to ZEISS FORUM requires an optional license and VISUCONNECT 600.
2 Kenny PI, Kozhaya K, Truong P, Weikert MP, Wang L, Hill WE, Koch DD. Efficacy of segmented axial length and AI approaches to IOL power calculation in short eyes. J Cataract Refract Surg. 2023 Mar 17.
3 Not available on CIRRUS 500.
4 Ehlers, Justis P., Joseph F. Griffith, and Sunil K. Srivastava. "Intraoperative OCT during Vitreoretinal Surgery for Dense Vitreous Hemorrhage in the PIONEER Study." Retina (Philadelphia, Pa.) 35.12 (2015): 2537.

Not all products, services or offers are approved or offered in every market and approved labeling and instructions may vary from one country to another. For country-specific product information, see the appropriate country website. Product specifications are subject to change in design and scope of delivery as a result of ongoing technical development.

ZEISS Retina Workflow
ZEISS Retina Workflow

 

ZEISS PROSPARA
ZEISS PROSPARA

 

ZEISS VISULAS yag laser
ZEISS VISULAS yag laser

 

 


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

Recent Articles

Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.